NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Blood Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Business Update



Deltex Medical new trial data show CardioQ reducing duration of hospital stays by one-third



October 5th, 2006

Deltex Medical Group plc (Deltex Medical or the company), the U.K.'s leading haemodynamic monitoring company, announced the recent publication in the British Journal of Surgery of the results of a major new clinical trial using its CardioQ oesophageal Doppler monitors.

The study conducted at the Freeman Hospital in Newcastle demonstrated that in cases where doctors used Deltex Medical's CardioQ treatment during surgery to help better maintain fluid balance and blood circulation, those patients suffered fewer complications and were fit for discharge three days sooner than those who did not receive the treatment.

Specifically, the study's main...


Source: Blood Weekly (2006-10-05)

NewsRx Passes
Advertisement
More Articles

------------------------
Security by Verisign PR Login